Implantable Cardiac Monitors Market in Asia Pacific is expected to register a CAGR of 8.9% during the forecast period (2018 - 2024) - KBV Research

Feb-19 | Report Format: Electronic (PDF)

Growth, Trends and Report Highlights

According to a new report Asia Pacific Implantable Cardiac Monitors Market, published by KBV research, the Asia Pacific Implantable Cardiac Monitors Market would witness market growth of 8.9% CAGR during the forecast period (2018 – 2024).

The Japan market would dominate the Asia Pacific Hospitals Implantable Cardiac Monitors Market by 2024, growing at a CAGR of 6.1 % during the forecast period. The China market is expected to witness a CAGR of 9.3% during (2018 - 2024). Additionally, The India market is expected to witness a CAGR of 9.3% during (2018 - 2024).

The Cardiac Arrhythmias market dominated the India Implantable Cardiac Monitors Market by Indication 2017, and would achieve a market value of $18.5 million by 2024, growing at a CAGR of 9.3 % during the forecast period. The Atrial Fibrillation market is expected to witness a CAGR of 10.3% during (2018 - 2024).

Full Report: https://www.kbvresearch.com/asia-pacific-implantable-cardiac-monitors-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abiomed, Inc., Abbott Laboratories, Boston Scientific Corporation, Reliant Heart, Inc., Astellas Pharma Inc., Biotronik SE & Co. KG, Agilent Technologies, Inc., Berlin Heart GmbH, Schiller AG, Jarvik Heart, Inc.

Asia Pacific Implantable Cardiac Monitors Market Segmentation

By Indication